Increased survivin mRNA in malignant pleural effusion is significantly correlated with survival

doi:10.1093/jjco/hyp151

中山醫學大學機構典藏 CSMUIR > 醫學院 > 醫學系 > 期刊論文 > Item 310902500/18209

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.csmu.edu.tw:8080/ir/handle/310902500/18209

题名:	Increased survivin mRNA in malignant pleural effusion is significantly correlated with survival
作者:	Lan, C.-C.;Wu, Y.-K.;Lee, C.-H.;Huang, Y.-C.;Huang, C.-Y.;Tsai, Y.-H.;Huang, S.-F.;Tsao, Tsao T.C.-Y.
关键词:	Cancer;Pleural effusion;Prognosis;Survivin
日期:	2009
上传时间:	2017-08-09T03:26:00Z (UTC)
ISSN:	3682811
摘要:	Objective: The sensitivity of cytologic examination of pleural effusions is variable and not predictive of prognosis. Survivin is an inhibitor of apoptosis that may be a novel diagnostic/prognostic marker of cancers. This study aimed to determine the diagnostic and prognostic value of measuring survivin mRNA levels in pleural effusions. Methods: Eighty-eight consecutive pleural effusion samples were examined for both cytology and survivin mRNA level. The accuracy of diagnosis and the correlation between survivin mRNA level and survival in malignant pleural effusion (MPE) were determined. Pleural effusions were divided into three groups: Group I, malignancy-associated (n = 44); Group II, inflammatory (n = 27); and Group III, transudative (n = 17). Results: Survivin mRNA levels in Group I (1.03±0.61, range 0-2.96) were significantly higher than those in Groups II (0.45±0.69, range 0-3.30) and III (0.08±0.22, range 00.71) (P, 0.001). Survivin mRNA level was significantly higher in MPE than in non-MPE. The cut-off value for survivin mRNA levels in pleural effusions was 0.074 for the diagnosis of malignancies, with sensitivity, specificity, and positive and negative predictive values of 96%, 45%, 45% and 96%, respectively. Survivin mRNA level in pleural effusions of cancer patients significantly correlated with poor survival. Conclusions: Survivin mRNA level is significantly higher in MPEs. Over-expression of survivin mRNA correlates with poor prognosis in cancer patients. © The Author (2009). Published by Oxford University Press. All rights reserved.
URI:	http://dx.doi.org/10.1093/jjco/hyp151 https://www.scopus.com/inward/record.uri?eid=2-s2.0-77950344002&doi=10.1093%2fjjco%2fhyp151&partnerID=40&md5=148c6b7b15d64b2e1c87eeb6f0582b5f https://ir.csmu.edu.tw:8080/ir/handle/310902500/18209
關聯:	Japanese Journal of Clinical Oncology 40(3) ,234-240
显示于类别:	[醫學系] 期刊論文

文件中的档案:

没有与此文件相关的档案.

在CSMUIR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....